D Langanke

Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer

D. Lüftner, Maggie Banys-Paluchowski, Andreas D. Hartkopf, Manuel Hörner et autres

de (code pays fourni par la source)

Standardized patient coaching improves therapy persistence in patients with hormone receptor–positive, HER2–negative advanced/metastatic breast cancer treated with abemaciclib

Manfred Welslau, Peter A. Fasching, Nicole Semmler-Lins, Lothar Mueller et autres

de, us (code pays fourni par la source)

Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

Thorsten Kuehn, Maggie Banys‐Paluchowski, Nina Ditsch, Elmar Stickeler et autres

de, tr, at, es, ch, gr, ro, fi, pl, pt, no, al, az, be, pe, in, cz, gb, si, jp, il, th, it, se (code pays fourni par la source)

Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer

Diana Lüftner, Maggie Banys‐Paluchowski, Andreas D. Hartkopf, Manuel Hörner et autres

de (code pays fourni par la source)

Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk

Volkmar Müller, Manuel Hörner, Marc Thill, Maggie Banys‐Paluchowski et autres

de, us (code pays fourni par la source)

Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Steffi Hartmann, Timo Basali, Maria Luisa Gasparri, Jana de Boniface et autres

de, ch, se, it, tr, no, es, at (code pays fourni par la source)

P014: Indirect comparison suggests ribociclib combined with nonsteroidal aromatase inhibitors is significantly more effective than tamoxifen in premenopausal women with Early Breast cancer

D. Lüftner, Malgorzata Banys-Paluchowski, AD Hartkopf, Michelle Horner et autres

Deutsches Konsortium Familiärer Brust- und Eierstockkrebs (FBREK) – Erste Erfahrungen als regionaler Kooperationspartner und Vorteile für betroffene Brustkrebspatient*innen

U. Hambsch, Vincent Strehlow, D Langanke

de (code pays fourni par la source)

Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Maggie Banys‐Paluchowski, Timo Basali, Steffi Hartmann, Jana de Boniface et autres

de, se, it, ch, at, tr, es, no (code pays fourni par la source)

Optimierte Technik der Reduktionsplastik mit freier Mamille – eine Fallserie

U Wolfeneck, D Langanke

de (code pays fourni par la source)

Marking of Target Lymph Nodes with carbon suspension in breast cancer patients undergoing neoadjuvant chemotherapy – first results from the AXSANA study (NCT04373655)

A Rief, Sylvia Hartmann, Maggie Banys‐Paluchowski, Jana de Boniface et autres

at, de, se, it, tr, us, gr, il, cz (code pays fourni par la source)

PREcoopERA Window-of-Opportunity trial of giredestrant+/- triptorelin vs. anastrozole+triptorelin in premenopausal patients with ER-positive/HER2-negative early breast cancer

Vesna Bjelic‐Radisic, Elisabetta Munzone, M. Untch, C. Denkert et autres

de, it, ch, us (code pays fourni par la source)